206 related articles for article (PubMed ID: 34451900)
1. Xenograft Zebrafish Models for the Development of Novel Anti-Hepatocellular Carcinoma Molecules.
Tonon F; Farra R; Zennaro C; Pozzato G; Truong N; Parisi S; Rizzolio F; Grassi M; Scaggiante B; Zanconati F; Bonazza D; Grassi G; Dapas B
Pharmaceuticals (Basel); 2021 Aug; 14(8):. PubMed ID: 34451900
[TBL] [Abstract][Full Text] [Related]
2. Transgenic zebrafish for modeling hepatocellular carcinoma.
Nakayama J; Gong Z
MedComm (2020); 2020 Sep; 1(2):140-156. PubMed ID: 34766114
[TBL] [Abstract][Full Text] [Related]
3. Rapid and cost-effective xenograft hepatocellular carcinoma model in Zebrafish for drug testing.
Tonon F; Zennaro C; Dapas B; Carraro M; Mariotti M; Grassi G
Int J Pharm; 2016 Dec; 515(1-2):583-591. PubMed ID: 27989824
[TBL] [Abstract][Full Text] [Related]
4. There Is Something Fishy About Liver Cancer: Zebrafish Models of Hepatocellular Carcinoma.
Wrighton PJ; Oderberg IM; Goessling W
Cell Mol Gastroenterol Hepatol; 2019; 8(3):347-363. PubMed ID: 31108233
[TBL] [Abstract][Full Text] [Related]
5. Identification of Novel Anti-Liver Cancer Small Molecules with Better Therapeutic Index than Sorafenib via Zebrafish Drug Screening Platform.
Lin HS; Huang YL; Wang YS; Hsiao E; Hsu TA; Shiao HY; Jiaang WT; Sampurna BP; Lin KH; Wu MS; Lai GM; Yuh CH
Cancers (Basel); 2019 May; 11(6):. PubMed ID: 31141996
[TBL] [Abstract][Full Text] [Related]
6. Thioacetamide accelerates steatohepatitis, cirrhosis and HCC by expressing HCV core protein in transgenic zebrafish Danio rerio.
Rekha RD; Amali AA; Her GM; Yeh YH; Gong HY; Hu SY; Lin GH; Wu JL
Toxicology; 2008 Jan; 243(1-2):11-22. PubMed ID: 17997003
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Liver Microenvironment during Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish.
Michael C; Martínez-Navarro FJ; de Oliveira S
J Vis Exp; 2021 Apr; (170):. PubMed ID: 33871465
[TBL] [Abstract][Full Text] [Related]
8. Zebrafish as a disease model for studying human hepatocellular carcinoma.
Lu JW; Ho YJ; Yang YJ; Liao HA; Ciou SC; Lin LI; Ou DL
World J Gastroenterol; 2015 Nov; 21(42):12042-58. PubMed ID: 26576090
[TBL] [Abstract][Full Text] [Related]
9. A preclinical evaluation of a novel multikinase inhibitor, SKLB-329, as a therapeutic agent against hepatocellular carcinoma.
Zhong L; Fu XY; Zou C; Yang LL; Zhou S; Yang J; Tang Y; Cheng C; Li LL; Xiang R; Chen LJ; Chen YZ; Wei YQ; Yang SY
Int J Cancer; 2014 Dec; 135(12):2972-83. PubMed ID: 24789676
[TBL] [Abstract][Full Text] [Related]
10. Liver-specific androgen receptor knockout attenuates early liver tumor development in zebrafish.
Li H; Li Y; Lu JW; Huo X; Gong Z
Sci Rep; 2019 Jul; 9(1):10645. PubMed ID: 31337771
[TBL] [Abstract][Full Text] [Related]
11. CRIPTO promotes an aggressive tumour phenotype and resistance to treatment in hepatocellular carcinoma.
Karkampouna S; van der Helm D; Gray PC; Chen L; Klima I; Grosjean J; Burgmans MC; Farina-Sarasqueta A; Snaar-Jagalska EB; Stroka DM; Terracciano L; van Hoek B; Schaapherder AF; Osanto S; Thalmann GN; Verspaget HW; Coenraad MJ; Kruithof-de Julio M
J Pathol; 2018 Jul; 245(3):297-310. PubMed ID: 29604056
[TBL] [Abstract][Full Text] [Related]
12. Inducible liver-specific overexpression of gankyrin in zebrafish results in spontaneous intrahepatic cholangiocarcinoma and hepatocellular carcinoma formation.
Huang SJ; Cheng CL; Chen JR; Gong HY; Liu W; Wu JL
Biochem Biophys Res Commun; 2017 Aug; 490(3):1052-1058. PubMed ID: 28668389
[TBL] [Abstract][Full Text] [Related]
13. Strategies to optimize siRNA delivery to hepatocellular carcinoma cells.
Scarabel L; Perrone F; Garziera M; Farra R; Grassi M; Musiani F; Russo Spena C; Salis B; De Stefano L; Toffoli G; Rizzolio F; Tonon F; Abrami M; Chiarappa G; Pozzato G; Forte G; Grassi G; Dapas B
Expert Opin Drug Deliv; 2017 Jun; 14(6):797-810. PubMed ID: 28266887
[TBL] [Abstract][Full Text] [Related]
14. Inducible and repressable oncogene-addicted hepatocellular carcinoma in Tet-on xmrk transgenic zebrafish.
Li Z; Huang X; Zhan H; Zeng Z; Li C; Spitsbergen JM; Meierjohann S; Schartl M; Gong Z
J Hepatol; 2012 Feb; 56(2):419-25. PubMed ID: 21888874
[TBL] [Abstract][Full Text] [Related]
15. Effects of sex hormones on liver tumor progression and regression in Myc/xmrk double oncogene transgenic zebrafish.
Li H; Lu JW; Huo X; Li Y; Li Z; Gong Z
Gen Comp Endocrinol; 2019 Jun; 277():112-121. PubMed ID: 30926469
[TBL] [Abstract][Full Text] [Related]
16. Transcriptomic analyses of oncogenic hepatocytes reveal common and different molecular pathways of hepatocarcinogenesis in different developmental stages and genders in kras
Huo X; Li H; Li Z; Yan C; Mathavan S; Liu J; Gong Z
Biochem Biophys Res Commun; 2019 Mar; 510(4):558-564. PubMed ID: 30739784
[TBL] [Abstract][Full Text] [Related]
17. Transcriptomic analysis of a transgenic zebrafish hepatocellular carcinoma model reveals a prominent role of immune responses in tumour progression and regression.
Li Z; Luo H; Li C; Huo X; Yan C; Huang X; Al-Haddawi M; Mathavan S; Gong Z
Int J Cancer; 2014 Oct; 135(7):1564-73. PubMed ID: 24550086
[TBL] [Abstract][Full Text] [Related]
18. Animal Models of Hepatocellular Carcinoma: The Role of Immune System and Tumor Microenvironment.
Macek Jilkova Z; Kurma K; Decaens T
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31581753
[TBL] [Abstract][Full Text] [Related]
19. An efficient method to generate xenograft tumor models of acute myeloid leukemia and hepatocellular carcinoma in adult zebrafish.
Khan N; Mahajan NK; Sinha P; Jayandharan GR
Blood Cells Mol Dis; 2019 Mar; 75():48-55. PubMed ID: 30616104
[TBL] [Abstract][Full Text] [Related]
20. Combinatorial Normalization of Liver-Derived Cytokine Pathways Alleviates Hepatic Tumor-Associated Cachexia in Zebrafish.
Fei F; Sun S; Li Q; Pei Z; Wang L; Zhang R; Luo F; Yu M; Wang X
Cancer Res; 2021 Feb; 81(4):873-884. PubMed ID: 33355239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
